Restoring function: Treatment effects in Alzheimer's disease patients treated with rivastigmine

被引：0
|
作者：
Venneri, A
Shanks, MF
Staff, RT
Pestell, SJ
Forbes, KE
Gemmell, HG
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A457 / A457
页数：1
相关论文
共 50 条
  • [1] Rivastigmine in the treatment of Alzheimer's disease
    Deleu, D
    EUROPEAN NEUROLOGY, 2001, 46 (02) : 111 - 111
  • [2] Effects of Rivastigmine in Alzheimer's Disease Patients with and Without Hallucinations
    Cummings, Jeffrey
    Emre, Murat
    Aarsland, Dag
    Tekin, Sibel
    Dronamraju, Nalina
    Lane, Roger
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (01) : 301 - 311
  • [3] Rivastigmine in the treatment of Alzheimer's disease: an update
    Onor, Maria Luisa
    Trevisiol, Marianna
    Aguglia, Eugenio
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01): : 17 - 32
  • [4] Disease stage in Alzheimer disease and treatment effects of rivastigmine
    Kurz, A
    Farlow, M
    Quarg, P
    Spiegel, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 (03): : 123 - 128
  • [5] Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine
    Dong-Churl Suh
    Stephen Arcona
    Simu K. Thomas
    Christopher Powers
    Adrian L. Rabinowicz
    Hyunchul Shin
    Dario Mirski
    Drugs & Aging, 2004, 21 : 395 - 403
  • [6] Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
    Suh, DC
    Arcona, S
    Thomas, SK
    Powers, C
    Rabinowicz, AL
    Shin, HC
    Mirski, D
    DRUGS & AGING, 2004, 21 (06) : 395 - 403
  • [7] Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease
    Moretti, Davide V.
    Frisoni, Giovanni B.
    Binetti, Giuliano
    Zanetti, Orazio
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [8] The response of patients with Alzheimer's disease to rivastigmine treatment is predicted by the rate of disease progression
    Farlow, MR
    Hake, AM
    Messina, J
    Veach, J
    Anand, R
    NEUROLOGY, 2000, 54 (07) : A469 - A470
  • [9] Evaluating improvements in rCBF in patients with Alzheimer's disease treated with rivastigmine using SPM
    Venneri, A
    Shanks, MF
    Staff, RT
    Pestell, SJ
    Forbes, KE
    Gemmell, HG
    NEUROIMAGE, 2001, 13 (06) : S1112 - S1112
  • [10] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline
    Evans, John Grimley
    Iakovidou, Vasso
    Tsolaki, Magda
    Holt, Francesca E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (02):
12345